Omega Healthcare Investors Q2 Earnings Call Highlights

Omega Healthcare Investors reported stronger Q2 results, with revenue rising to $328 million and net income reaching $363 million, boosted by a $247 million gain on asset sales. Adjusted FFO was $0.83 per share, and full-year 2026 AFFO guidance was raised to $3.22–$3.26 per share. The company significantly strengthened its balance sheet by using roughly $700 million of asset-sale and loan-repayment proceeds to reduce revolver borrowings to $6 million. Portfolio EBITDA coverage improved to 1.65x, while leverage stood at 3.3x. Management expects investment activity to accelerate in the second half of 2026 and into 2027, including expansion in skilled nursing, senior housing and U.K. care homes. Omega is placing greater emphasis on RIDEA operating investments, which it expects to generate higher returns than traditional triple-net deals.

Omega Healthcare Investors NYSE: OHI reported second-quarter 2026 results marked by higher revenue, a large gain from asset sales, improved portfolio coverage and an increased full-year Adjusted FFO outlook, while management outlined plans for greater investment activity in the second half of the year. The call was also the 100th and final earnings call for CEO Taylor Pickett and CFO Bob Stephenson, who are retiring after 25 years leading the company. Pickett said Omega has evolved from a nearly exclusively skilled-nursing-focused portfolio in 2001 to one with greater senior housing and U.K. care home exposure, as well as a growing operating portfolio.

“I am very confident in Omega’s future growth prospects,” Pickett said, pointing to the company’s culture, expanding capital-allocation products and management team under President Matthew Gourmand.

Revenue totaled $328 million in the second quarter, compared with $283 million in the year-ago period. Chief Accounting Officer Neal Ballew said the increase primarily reflected revenue from net new investments completed during 2025 and 2026, annual escalators and portfolio-management activity.

Net income available to common shareholders was $363 million, or $1.19 per share, compared with $137 million, or $0.46 per share, a year earlier. The increase was primarily driven by a $247 million gain on asset sales, largely related to the sale of 18 CommuniCare facilities. Adjusted funds from operations, or AFFO, were $261 million, or $0.83 per share, while funds available for distribution, or FAD, were $248 million, or $0.78 per share. Ballew said AFFO rose by approximately one-quarter of a penny per share from the first quarter. Contributions from new investments, annual escalators and lower interest expense were mostly offset by lost revenue associated with asset sales and loan repayments during the past two quarters. Omega completed $377 million of new investments during the first and second quarters. Asset sales totaling $597 million and loan repayments of $209 million over the past two quarters reduced second-quarter AFFO by $7.5 million. About $700 million of asset-sale proceeds and loan repayments during the quarter enabled Omega to reduce borrowings on its $2 billion revolver to $6 million. At June 30, the company reported a 6.5x fixed-charge coverage ratio and leverage of 3.3x. The company raised and tightened its 2026 AFFO guidance to $3.22 to $3.26 per share, from prior guidance of $3.19 to $3.25 per share. The revised midpoint of $3.24 represents a $0.02 increase from the midpoint of April guidance. However, Ballew said asset sales and repayments complet...